Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications
| Autor: | Claudia Dellanoce, Rossella Morandini, Carlo Valtulina, Maria Sessa, Oriana Paoletti, Maurizio Tala, Sophie Testa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class lcsh:Medicine 030204 cardiovascular system & hematology Dabigatran 03 medical and health sciences 0302 clinical medicine idarucizumab Internal Medicine medicine dabigatran 030212 general & internal medicine Intensive care medicine Stroke business.industry Anticoagulant anticoagulant lcsh:R Idarucizumab Atrial fibrillation Articles Acute bleeding medicine.disease DOACs plasma measurement business Venous thromboembolism Thrombotic complication medicine.drug |
| Zdroj: | European Journal of Case Reports in Internal Medicine (2018) European Journal of Case Reports in Internal Medicine |
| Popis: | Oral anticoagulant therapy is recommended for the prevention and treatment of venous thromboembolism and to prevent stroke in non-valvular atrial fibrillation. Until a few years ago, vitamin K antagonists were the only drugs available, but direct oral anticoagulants have recently been introduced into clinical practice for the same clinical indications. Unlike the situation with VKAs, fixed-dose administration was proposed for DOACs, without the necessity for routine laboratory monitoring. However, in clinical practice a high inter-variability in DOAC plasma levels, independently of the type of drug and patient characteristics, was observed and the importance of measuring DOAC anticoagulant activity to support treatment decisions has therefore been recognized. We describe two clinical cases in order to highlight the role and importance of dabigatran-specific measurements to guide patient management in case of major complications. LEARNING POINT Direct oral anticoagulants (DOACs) have been used in clinical practice at fixed doses without laboratory monitoring. However, the importance of measuring DOAC anticoagulant activity to support treatment decisions, particularly in emergency conditions, has been recognized. The clinical value of DOAC measurement is highlighted in the two described cases where the anticoagulation level was taken into consideration when deciding on treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|